Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

SYSMEX CORP Lowers Consolidated Full-year Outlook for FY Ending March 31, 2013


Tuesday, 6 Nov 2012 01:00am EST 

SYSMEX CORP announced that it has lowered its consolidated full-year outlook for revenue from JPY 148,000 million to JPY 140,000 million, operating profit from JPY 21,000 million to JPY 20,000 million, ordinary profit from JPY 21,000 million to JPY 19,500 million, net profit from JPY 13,000 million to JPY 12,100 million and earning per share from JPY 126.45 to JPY 117.59 for the fiscal year ending March 31, 2013. This is due to the decreased sales of blood cell count examination related businesses, as well as the recording of foreign exchange loss. According to I/B/E/S Estimates, analysts on average are expecting the Company to report full-year revenue of JPY 144.86 billion and net profit of JPY 13.57 billion. 

Company Quote

4040.0
25.0 +0.62%
10:30pm EDT